NTZ exhibited significant anti-arthritic activity through the inhibition of the STAT-3 and NF-κB pathways, emphasizing its potential as a therapeutic option for rheumatoid arthritis. The gene discussed is NFKB1; the disease is rheumatoid arthritis.